RA

Riju Angik Chimote

Active Director Designated Partner DIN 10156451
DIN 10156451 First appointment May 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Riju Angik Chimote

Data last updated:

Riju Angik Chimote is a Designated Partner at Embryolab Evolution Llp (since 2023). The company operates in Healthcare.

DIN 10156451
Primary Designation Designated Partner
Industry Healthcare
First Appointment 10 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 May 20232023Active

Board colleagues of Riju Angik Chimote

NameDINCompanyDesignation
Amogh Natchandra Chimote07597615Embryolab Evolution LlpDesignated Partner
Nishad Natchandra Chimote00226534Embryolab Evolution LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Embryolab Evolution Llp
Premium access

Shareholding and investment profile for Riju Angik Chimote

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Riju Angik Chimote

Riju Angik Chimote currently holds 1 directorship: Embryolab Evolution Llp (Designated Partner, since 10 May 2023).

Riju Angik Chimote was first appointed on 10 May 2023 as Designated Partner at Embryolab Evolution Llp.

The current boards of Riju Angik Chimote's companies include Amogh Natchandra Chimote (Embryolab Evolution Llp), Nishad Natchandra Chimote (Embryolab Evolution Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available